$17.59
$0.42
(2.45%)
Quote as of 4:00 PM EST on 02/13/12
Amylin Pharmaceuticals, Inc.
NASDAQ:AMLN
|
$17.59
$0.42
(2.45%)
|
|
| Today's Open | $17.59 |
|---|---|
| Previous Close | $17.17 |
| Daily Range | $17.41 - $17.80 |
| 52-Week Range | $8.03 - $18.30 |
| Market Cap | $2.57B |
| P/E Ratio | 190.78 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 3,364,048 |
| Average Daily Volume | 4,798,714 |
| Current FY EPS | -$1.48 |
AMLN Information
| Description |
|---|
| A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
5 of Last Week's Biggest Winners
The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and
Novo Nordisk Posts Solid 4Q - Analyst Blog
Revenues Skyrocket at Merged Alkermes - Analyst Blog
Amylin Pharmaceuticals Shares Popped Again: What You Need to Know
New Study for Alkermes' Vivitrol - Analyst Blog
Company News for January 31, 2012 - Corporate Summary
Zyprexa Pulls Down Lilly's 4Q Sales - Analyst Blog
